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Abstract
Holoprosencephaly (HPE) is a spectrum of brain and facial malformations primarily reflecting genetic factors, such
as chromosomal abnormalities and gene mutations. Here, we present a clinical and molecular analysis of 195
probands with HPE or microforms; approximately 72% of the patients were derived from the Latin American Collabo-
rative Study of Congenital Malformations (ECLAMC), and 82% of the patients were newborns. Alobar HPE was the
predominant brain defect in almost all facial defect categories, except for patients without oral cleft and median or lat-
eral oral clefts. Ethmocephaly, cebocephaly, and premaxillary agenesis were primarily observed among female pa-
tients. Premaxillary agenesis occurred in six of the nine diabetic mothers. Recurrence of HPE or microform was
approximately 19%. The frequency of microdeletions, detected using Multiplex Ligation-dependant Probe Amplifica-
tion (MLPA) was 17% in patients with a normal karyotype. Cytogenetics or QF-PCR analyses revealed chromosomal
anomalies in 27% of the probands. Mutational analyses in genes SHH, ZIC2, SIX3 and TGIF were performed in 119
patients, revealing eight mutations in SHH, two mutations in SIX3 and two mutations in ZIC2. Thus, a detailed clinical
description of new HPE cases with identified genetic anomalies might establish genotypic and phenotypic correla-
tions and contribute to the development of additional strategies for the analysis of new cases.
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Introduction
Holoprosencephaly (HPE, MIM 236100) is a com-
plex brain malformation affecting both the forebrain and
the face. This condition can be described according to cere-
bral malformation severity: lobar, semi-lobar, alobar and
middle interhemispheric variant (MIH-HPE) (Demyer and
Zeman, 1963; Simon et al., 2002). Facial anomalies are
variable, ranging from cyclopia, ethmocephaly or ceboce-
phaly to mild forms, such as ocular hypotelorism or single
median maxillary central incisor (SMMCI) (Cohen Jr,
1989; Richieri-Costa and Ribeiro, 2006; El-Jaick et al.,
2007a). In HPE families, mild facial anomalies can occur
without cerebral malformation, and these anomalies are
considered risk factors for HPE in subsequent offspring
(Berry et al., 1984; El-Jaick et al., 2005). Cerebral malfor-
mations without facial evidence occur in 10-20% of HPE
patients (Cohen Jr, 1989).
The etiology of HPE is complex, including both ge-
netic and environmental factors (Barr Jr et al., 1983; Bel-
loni et al., 1996; Cohen Jr and Shiota, 2002; Dubourg et al.,
2007). Chromosomal anomalies represent approximately
45% of HPE cases. Multiple malformation syndromes with
normal karyotypes, such as Smith-Lemli-Optiz, Pallister
Hall and velo-cardio-facial Syndrome, correspond to 25%
of HPE cases (reviewed by Dubourg et al., 2007). Numer-
ous mutations in the genes involved in the development of
the forebrain and midline face during embryogenesis have
been described. The four genes typically associated with
HPE cases are SHH [HPE3, MIM 142945] (Roessler et al.,
1996), ZIC2 [HPE5, MIM 609637] (Brown et al., 1998),
SIX3 [HPE2, MIM 157170] (Wallis et al., 1999), and TGIF
[HPE4, MIM 142946] (Gripp et al., 2000). Mutations in
one of these genes correspond to 10-20% of non-syndromic
cases (Orioli et al., 2001; Dubourg et al., 2004). Other
genes associated with HPE, although to a lesser degree, in-
clude PTCH [HPE7, MIM 610828] (Ming et al., 2002),
TDGF1 [MIM 187395] (De la Cruz et al., 2002), GLI2
[HPE9, MIM 610829] (Roessler et al., 2003), DHCR7
[SLOS, MIM 270400] (Shim et al., 2004), FAST1/FOXH1
[MIM 603621] (Roessler et al., 2008), DISP1 [MIM
607502] (Roessler et al., 2009a), FGF8 [HH6, MIM
612702] (Arauz et al., 2010), and CDON [HPE11, MIM
614226] (Bae et al., 2011).
The phenotypic variability and incomplete penetran-
ce make it difficult to conduct genetic counseling in HPE.
Families typically present autosomal dominant, but also
autosomal recessive and possibly X-linked inheritance
(Ming and Muenke, 1998; Wallis and Muenke, 1999; Mue-
nke and Beachy, 2001). Autosomal dominant inheritance
has an estimated penetrance of 80% (Odent et al., 1998),
and the same mutation segregating within a family can
present asymptomatic, mild and severe forms of the disease
(Roessler et al., 1996; El-Jaick et al., 2005). We recently
analyzed HPE cases from the ECLAMC (Estudio Latino-
americano de Malformaciones Congénitas-Latin-
American Collaborative Study of Congenital Malforma-
tions) since 2000 (Orioli et al., 2001; El-Jaick et al., 2005,
El-Jaick et al., 2007a), and in the present study, we evaluate
the contribution of chromosomal anomalies and mutations
in the four main HPE genes (SHH, SIX3, TGIF, and ZIC2).
Materials and Methods
ECLAMC
Most of the families studied (140/195; 72%) were de-
rived from the ECLAMC (Estudio Latinoamericano de
Malformaciones Congénitas-Latin American Collabora-
tive Study of Congenital Malformations). ECLAMC is a
hospital-based registry, which examines births in South
America (Castilla and Orioli, 2004). In 1998, the ECLAMC
initiated a molecular epidemiological program, called
MOLECLAMC, and biological samples from newborns
presenting congenital malformations were collected for
molecular analysis.
Samples from MOLECLAMC primarily comprise
blood spots on filter paper (Schleicher and Schuell no. 903
or IsoCode), and a pediatrician interviewed the mothers of
the malformed infants using a form with 50 questions con-
cerning risk factors, including environmental exposure,
history of other familial congenital defects, and parental
consanguinity (Castilla and Orioli, 2004). The DNA repos-
itory of MOLECLAMC also receives samples from pedia-
tricians and geneticists associated with the ECLAMC.
These cases occasionally involve older patients, represent-
ing 28% (55/195) of the families presented herein.
Patients
The patients were referred based on typical HPE fa-
cial dysmorphisms, with or without confirmation through
brain imaging, on SMMCI or a family history of HPE.
Aneuploidy analyses were performed on some HPE pa-
tients with no informed karyotype. Chromosomal micro-
rearrangements were evaluated in some HPE and SMMCI
patients without mutations in the four main HPE genes and
no known chromosomal anomalies.
The patients referred to the Birth Defects Laboratory
at the Federal University of Rio de Janeiro were analyzed in
the last 14 years. Initially, we only analyzed mutations in
the four main HPE genes. In 2008, the laboratory imple-
mented the MLPA (Multiplex Ligation-Dependent Probe
Amplification) technique, and in 2010, we initiated studies
to screen for trisomies using QF-PCR. Not all patients
could be studied using all techniques, reflecting the lack of
adequate DNA quantity and quality, particularly for older
samples.
The Ethics Committee of the ECLAMC (CEMIC:
Centro de Educación Médica e Investigación Clínica, Bue-
nos Aires, Argentina, IORG-0001315) approved the pro-
ject, and written informed consent was obtained from adult
patients and the parents of infant patients.
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DNA extraction
The DNA from blood spotted onto Schleicher and
Schuell no. 903 filter paper (Schleicher & Schuell Inc.,
Keene, NH, USA) was extracted using QIAamp DNA Mini
Kit (Qiagen, Valencia, CA, USA) or DNeasy 96 Tissue Kit
(Qiagen, Valencia, CA, USA), and DNA from blood spot-
ted onto IsoCode filter papers (Schleicher & Schuell Inc.,
Keene, NH, USA) was extracted through boiling in water.
The DNA from peripheral blood samples on EDTA was ex-
tracted through salting out (Miller et al., 1988).
PCR and direct sequencing
The coding region and exon-intron boundaries of
SHH, SIX3, TGIF, and ZIC2 were amplified as previously
described (El-Jaick 2007a,b; Savastano et al., 2014). Auto-
mated sequencing was performed using MegaBACE 1000
(Amersham Pharmacia Biotech In, London, UK) or ABI
Prism 377 (Applied Biosystems, Foster City, CA, USA)
DNA sequencing systems. The electropherograms were an-
alyzed using Sequencher software (Gene Codes Corpora-
tion, Ann Arbor, MI, USA). SIFT and PolyPhen2 online
software programs were used to predict the effects of non-
synonimous mutations. The gene mutation nomenclature
used in this study was consistent with the recommendations
of den Dunnen and Antonarakis (2000), and updates are
available on the website for the Human Genome Variation
Society (HGVS).
Micro-rearrangements analysis
Submicroscopic deletions or gains were screened
through Multiplex Ligation-Dependent Probe Amplifica-
tion (MLPA) (Schouten et al., 2002), using the MLPA Kit
P187 or the MLPA Kit P187 B1 (MRC-Holland, Amster-
dam, Netherlands). These kits contain probes against the
HPE genes SHH, SIX3, TGIF, ZIC2, PTCH, GLI2, and can-
didate genes TRAPPC10 and FBXW11. Normalization and
analysis were performed using Coffalyser (Coffa et al.,
2008) or GeneMarker (Softgenetics, State College, PA,
USA) software programs.
QF-PCR analysis of trisomies
HPE patients without confirmed karyotypes were fur-
ther tested for aneuploidies on chromosomes 13, 18, 21 and
X through QF-PCR, using the Aneufast Multiplex QF-PCR
Kit (Genomed AG, Wollerau, Switzerland). Patients with
alterations in more than one marker for the same chromo-
some were subjected to further tests using chromosome
specific back-up markers. The analyses were performed us-
ing GeneMarker (Softgenetics, State College, PA, USA).
Results
The series
From 1998 to 2012 a total of 195 probands were re-
ferred for genetic analysis of the HPE genes. Most of the
samples (160/195; 82.1%) were obtained from newborns,
livebirths (145/195; 74.4%) or stillbirths (15/195; 7.7%),
but the sample also included children of different ages
(26/195; 13.3%), adults (3/195; 1.5%), four fetuses (4/195;
2.1%), and two (1.0%) of unknown ages. Females were
predominant, with 112 females (58.6%) vs. 79 males
(41.4%), and this predominance was significant when con-
sidering the sex ratio expected at birth (2 = 7.10; P = 0.008;
GL = 1). One patient had no information, and three patients
were intersexes. There were 110 patients with isolated HPE
or microform (“isolated cases”), and 85 patients (43.6%)
with other malformations unrelated to the HPE spectrum
(“associated cases”). The occurrence of HPE was verified
through pre or postnatal brain imaging or autopsy in 155
probands (79.5%). Forty-one cases with specified HPE
types presented with alobar HPE type (41/79; 51.9%), 29
cases presented with semilobar HPE type (29/79; 36.7%),
and nine cases presented with lobar HPE type (9/79;
11.4%). In 97 probands HPE was not specified, although
there was a suspicion of interhemispheric variant of HPE in
three cases. Nineteen patients (19/195; 9.7%) had no HPE
in cerebral imaging: one patient presented premaxillary
agenesis and anophtalmia, two patients were obligated car-
rier mothers, and 16 patients had SMMCI. Five of the 16
SMMCI patients exhibited a mild phenotype without men-
tal deficiency and additional defects, such as microcephaly,
choanal atresia, lacrimal conduct atresia, or ocular hypo-
telorism.
The facial descriptions of the 195 patients, including
the two obligated carrier mothers, were classified as cyclo-
pia (19 cases), ethmocephaly (6 cases), cebocephaly (17
cases), and premaxillary agenesis (41 cases). The facial
types in 172 patients were distributed among seven addi-
tional categories: median cleft lip (8 cases), bilateral or uni-
lateral cleft lip with or without cleft palate (8 cases), cleft
palate (5 cases), no oral cleft (60 cases), no oral cleft with
SMMCI (16 cases), atypical facial cleft (4 cases), and no
specified facial type (11 cases). The numbers of patients in
these eleven facial type categories are presented in Table 1.
Alobar HPE was frequently observed in almost all fa-
cial categories, except for the median, lateral and no oral
cleft categories where semilobar HPE was apparently more
common (Table 1). Interestingly, the semilobar HPE type
was observed in four of five cases of trisomy 13 with HPE
type specified. A significant excess of females was ob-
served in the ethmocephaly, cebocephaly, and premaxillary
agenesis categories, and the male proportion was normal in
the other categories. The proportion of other defects unre-
lated to the HPE spectrum did not vary among the facial
categories. The recurrence of HPE or microform in the 195
families was approximately 19% (37/195; 95% CI: 13.9-
25.3) without variation among the facial groups. Parental
consanguinity is a rare event, with only three cases among
the 158 cases specified for the data (1.9%; 95% CI: 0.5-
5.9). The mean maternal age among 149 mothers was 26.9
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years (95% CI: 25.8-27.8), and did not vary among the fa-
cial groups. There were nine cases of maternal diabetes
among the 139 probands (6.5%, 95% CI: 3.2-12.3), and six
of these cases exhibited premaxillary agenesis. The propor-
tion of chromosomal anomalies or gene mutations did not
differ among the facial categories (Table 1).
Micro-rearrangement analysis and chromosomal
anomalies
MLPA screening was performed in 58 patients: ten
patients with common trisomies (chromosomes 13 and 18),
five patients with structural chromosomal anomalies, 23
patients with normal karyotypes, and 20 patients without
karyotype information, showing failure in 15 cases and in-
conclusive results in eight cases. Among the 35 cases with
MLPA results, 28 patients had HPE and seven patients had
microforms. We also observed normal MLPA results in 27
cases, in which 14 patients had normal karyotypes, one pa-
tient exhibited 46,XX, inv(5) (p14.3; q23.1), and 12 cases
showed no karyotype information. Altered MLPA results
were observed in three of the 17 cases with normal karyo-
types (17.6%; 95% CI: 4.7-44.2) or in three of the 29 cases
with or without informed karyotypes (10.3%; 95% CI:
2.7-28.5). We detected two ZIC2 deletions and one deletion
encompassing the SIX3 and SIX2 genes. The other altered
MLPA results were observed in two cases of trisomy 13,
and one case of 18p-, t(6;7) and t(7;14). An affected sibling
of the patient with t(6;7) was also examined to verify the
occurrence of the SHH deletion. Table 2 shows the pheno-
type and MLPA alterations observed in individuals with
gene deletions.
Informed karyotypes were observed in 65 of the
probands, and 20 patients had chromosome anomalies. We
successfully performed QF-PCR analysis on 26 probands
without informed karyotypes and detected chromosomal
aneuploidies in five patients: one case of trisomy 21, one
case of trisomy 18, and three cases of trisomy 13. Con-
sidering informed karyotype and the QF-PCR analysis, we
obtained karyotype information for 91 patients (46.7%).
Chromosomal anomalies, including aneuploidies or struc-
tural anomalies, were observed in 25/91 patients (27.5%;
95% CI: 18.9-38.0). The increased frequency of chromo-
somal abnormalities was observed in patients with associ-
ated HPE (22/51; 43.1%). Only three patients with isolated
HPE or microform (3/40; 7.5%) showed chromosomal ab-
errations: 18p-, inv(5) and an unspecified chromo-
somopathy. The inv(5) observed in a SMMCI patient, was
also observed in her father and brother, both exhibiting a
normal phenotype.
Mutation screening
Mutation analyses were successfully performed in
120 patients for SHH and TGIF, 125 patients for SIX3, and
151 patients for ZIC2. All four genes were successfully se-
quenced in 119 patients: 45 patients had HPE, or micro-
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form, and also other malformations not associated with the
HPE spectrum, and 74 patients had isolated HPE or micro-
form. Most of the studied patients (86/119; 72.3%) were
newborns (81 livebirths, and five stillbirths), but the sample
also included 25 children of different ages (25/119; 21.0%)
ranging from 4 months to 17 years, three adults (3/119;
2.5%), and four fetuses (4/119; 3.4%). We could not re-
trieve information for the age of one patient. Among the
119 studied patients, 36 patients had normal karyotypes (18
males and 18 females), 19 patients had normal QF-PCR re-
sults, and seven patients had chromosomal anomalies. The
remaining 57 patients had unknown karyotypes (18 associ-
ated, and 39 isolated HPE or microform), representing
47.9% of the studied cohort.
In total, 47 variants were detected, 35 variants were
classified as benign or of unknown significance based on
several features, including the presence of the variant in
population SNP databases, synonymous benign variants
predicted using PolyPhen and SIFT software, or UTR and
intronic variants with unknown significance. We detected
12 damaging mutations in 119 probands (10.1%; 95% CI:
5.6-17.3) (Table 3). The pathogenetic mutations included
eight SHH gene mutations (66%), two SIX3 gene mutations
(17%), and two ZIC2 gene mutations (17%). All 12 patients
presented isolated HPE or microform.
The mutation frequency is similar (10.9%) among the
probands with normal karyotype or QF-PCR results (six
mutations out of 55 cases). The pedigrees of the six families
with mutation recurrences are presented in Figure 1. The
parents from six probands were available for study to deter-
mine the mutation inheritance. The clinical characteriza-
tion and mutations identified in the probands and parents
are summarized in Table 3. Figure 2 shows clinical photos
and eletropherograms from the three most recently studied
mutated patients. The other patients have been previously
described (Orioli et al., 2001; El-Jaick et al., 2005, 2007a).
SHH mutations
We detected eight mutations in the SHH gene. Three
patients have been previously described. El-Jaick et al.
(2005) described a newborn girl presenting the mutation c.
332T > A, p.(I111N), with alobar HPE and premaxillary
agenesis, inherited from the mother affected with SMMCI
and hypotelorism. Orioli et al. (2001) described the other
two patients: 1) a 8-year-old male presenting the mutation
c. 419A > C, p.(H140P) without specified HPE type, ocular
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Table 2 - Chromosome deletions in patients with holoprosencephaly (HPE).
Patient n. Sex HPE type Facial type Other features Karyotype results MLPA results
439a M Alobar Ethmocephaly microcephaly (CC: 23 cm), cranial fontanels
and sutures not palpable, high frontal hair; fron-
tal proboscis; eyes separated by 2 mm skin;
fused iris; absent nose; small mouth; short and
broad neck; palmar simian creases, 5th fingers
clinodactyly, absent flexion creases on left 3rd
and 4th fingers, and 3rd right finger; small penis;
hypospadias; hypoplasic scrotal folds; right
criptorquidia; anal atresia; left renal cyst.
46, XY, t(6;7)(p21;
q36)
del SHH
568a M Alobar Cyclopia Microcephaly (CC: 22 cm); proboscide over the
eye; microstomia; thin lips with down deviated
comisssures; low-set ears; short neck with ex-
cess skin; bilateral single palmar crease; clino-
dactyly of 5th finger of both hands; prominent
heels; imperforate anus (apparently without fis-
tula); absence of sacrum; X-rays: hemivertebra
at L5.
46, XY, t(6;7)(p21;
q36)
del SHH
3877 F Unknown Unknown Fetal US: triventricular hydrocephalus, and sin-
gle umbilical artery.
46, XX, -7, +der(7)
, t(7;14) (q36;q31)
pat
del SHH
817 M Unknown No oral cleft Ocular hypotelorism; narrow palate; low inser-
tion of hair on the neck; hirsutism.
46, XY del ZIC2
1233 M Unknown Cyclopia Small mouth; separated ocular
globes, proboscide; microstomia; dysmorphic
ears with helices folded over the antihelices.
46, XY del ZIC2
6230 M Alobar Cyclopia Microcephaly; fused thalami; arrinia. 46, XY del SIX2 and SIX3
4772 F Alobar Cyclopia Microcephaly (CC: 23 cm); single ocular globe
with two iris; proboscide over the eye; malar
hypoplasia; adrenal hypoplasia.
46, XX, del
18p(11.2)
del TGIF1
aPatient n. 568 is brother of patient n. 439. Chomosomes were reanalyzed after the birth of the second affected son in this family.
MLPA : Multiplex Ligation-Dependent Probe Amplification.
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hypotelorism, SMMCI, and strabism, inherited from the
mother affected with mild ocular hypotelorism; and 2) a
newborn male presenting the mutation c. 548G > T,
p.(C183F) with alobar HPE, microcephaly, ocular hypo-
telorism, bilateral microphthalmia without lid opening, a
single nostril with choanal atresia, and an ogival palate.
The mutation c. 214C > T, p.(R72*) likely represents
a de novo mutation in a female infant with lobar HPE,
microcephaly, and ocular hypotelorism (El-Jaick, 2005).
The mutation c. 381delC, p.(W128Gfs*58) was observed
in a male newborn prenatally diagnosed with HPE, present-
ing a typical face, with microcephaly, ocular hypotelorism,
cleft lip, micropenis, and rudimentary scrotum with non-
palpable testes (Figure 2 e, f, and g). An analysis of the fam-
ily history revealed a paternal half-brother with HPE and a
father with ocular hypotelorism. Unfortunately, DNA from
the father and half-brother was not available. The mutation
c. 482T > A, p.(L161Q) was observed in a female proband
with HPE, microcephaly, ocular hypotelorism, premaxil-
lary agenesis, flat nose, and pectus excavatum, presenting
the karyotype 46,XX, 16qh+. The family history revealed a
sister with HPE. The mutation was inherited from the fa-
ther, who was not affected (El-Jaick, 2005). The mutation
c. 548G > A, p.(C183Y) was detected in a male proband
with alobar HPE, showing the absence of the corpus callo-
sum and fusion of the thalami, a cystic area in the region of
the cerebellar vermis, extending cranially through the
midline, lissencephaly, microcephaly, ocular hypotelorism,
small palpebral fissures, single nostril, and premaxillary
agenesis (Figure 2, a and b). The patient presented CC = 22
cm at birth (< 3rd centile) and 29.8 cm at 13 months of age
(< 3rd centile), with a normal karyotype (46,XY). The pa-
tient evolved with significant psychomotor retardation,
feeding difficulties and difficult to control seizures, dying
at age five. The parents were not available for this study.
The mutation c. 718A > C, p.(T240P) was present in a fe-
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Figure 1 - The pedigrees of families with segregating mutations in HPE
genes. Filled symbols indicate frank HPE; partially filled symbols indicate
HPE microforms; asterisks indicate mutation carriers confirmed through
sequencing; and arrows indicate probands.
male infant with microcephaly, ocular hypotelorism, single
nostril, and pronounced ogival palate (Figure 2, c and d).
The family history revealed a nephew of the maternal
grandmother with hydrocephalus, and a paternal uncle with
a clubfoot. No relatives were available for further analysis
in this study.
SIX3 mutations
SIX3 mutations were identified in two probands. The
mutation c. 522CA, p.(Y174*) was detected in a woman
with ocular hypotelorism and normal intelligence (El-
Jaick, 2005). The patient was pregnant with two fetuses af-
fected with HPE. The mutation c. 686C > T, p.(P229L) was
observed in an eight-year-old male patient (El-Jaick et al.,
2007a) with SMMCI, ocular hypotelorism, mild bilateral
distichiasis, mammary hypertelorism, hyperfolded helices,
an indistinct and short philtrum, mild mandibular
prognatism, normal stature, and a mild learning delay but
normal cerebral CT.
ZIC2 mutations
Mutations in the ZIC2 gene were detected in two
probands. Orioli et al. (2001) previously described a
6-month-old female, presenting the mutation c.
857_858delAC, p.(H286Rfs*80), with semilobar HPE,
microcephaly, trigonocephaly and a relatively non-dys-
morphic face.
The mutation c. 1411_1415delGTGTC,
p.(V471Rfs*57) was detected in a male infant with a prena-
tal diagnosis of semilobar HPE, presenting microcephaly,
ocular hypertelorism, and a rare cleft nose. The family his-
tory revealed a paternal half-sister with HPE. The father
presented the same mutation, likely in mosaicism, with
mild ocular hypotelorism (Savastano et al., 2014).
Discussion
More than 80% (160/195) of the patients in this study
were newborn, and two-thirds of these patients were ob-
tained from the ECLAMC, except for the older patients and
those with SMMCI. The controlled epidemiological vari-
ables, such as sex, maternal age, maternal diabetes, parental
consanguinity, chromosomal or gene defects, and the recur-
rence of HPE or microform in the family, showed that this
sample did not differ from that previously studied at
ECLAMC (Orioli and Castilla, 2007).
The phenotypic variables, such as type of HPE, facial
types, presence of other cerebral defects or the presence of
other defects not associated with the HPE spectrum, dif-
fered from those previously observed (Orioli and Castilla,
2007) when newborn patients may not present features,
such as SMMCI and/or mental retardation. The expansion
of the classical facial classification in HPE (DeMyers et al.,
1964) resulted in 11 facial types. We examined some epide-
miological and phenotypic variables according to these 11
facial types, to detect useful differences among them, as a
facial description is more easily obtained than cerebral im-
aging or karyotype. The semilobar HPE type was less fre-
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Figure 2 - HPE phenotypes and associated mutations. a) Missense mutation c.548G > A (p.C183Y) in exon 2 of SHH in patient ID 2086. b) Male patient
(ID 2086) with microcephaly, ocular hypotelorism, small ocular fissures, and premaxillary agenesis. c) Missense mutation c.718A > C (p.T240P in the
third exon of SHH in patient ID 2815. d) Female newborn (ID 2815) with microcephaly, ocular hypotelorism, single nostril and accentuated ogival palate.
e) Deletion (c.381delC) in the SHH gene in patient ID 5327, which alters the reading frame and generates a stop codon at 58 residues after the deletion. f)
Male newborn (ID 5327) prenatally diagnosed as HPE and presenting single nostril, microphtalmia, ocular hypotelorism, median cleft lip, and
microcephaly. g) Picture of patient ID 5327 showing micropenis and rudimentary scrotum with non-palpable testes.
quently observed among the four classical facial types, but
the sample is too small to access the significance of this
finding. Because the semilobar HPE type was more fre-
quently observed in trisomy 13 cases (four among five with
HPE type specified), we attempted to characterize the other
chromosome anomalies with specified HPE types and ob-
served only alobar HPE in four cases (18 trisomy, 21
trisomy, t(6;7), and del 18p).
The slight female predominance of 1.4:1 (fe-
male:male) observed in the present study was consistent
with that previously observed in other studies (Croen et al.,
1996; Forrester and Merz, 2000; Mercier et al., 2011). This
female predominance was restricted to three facial types:
ethmocephaly, cebocephaly, and premaxillary agenesis.
Patients with cyclopia showed a normal male proportion.
This sexual difference might reflect causal differences of
HPE associated with facial types. The increased frequency
to be confirmed of maternal diabetes in patients with pre-
maxillary agenesis, and ZIC2 mutations typically associ-
ated with normal or mildly affected faces (Brown et al.,
2001), might be examples of association between cause and
facial type.
Chromosomal anomalies are described in 32% to
41% of HPE cases, and trisomy 13 is the most frequently
observed anomaly (reviewed by Solomon et al., 2010a). In
the present study, karyotyping or QF-PCR analyses re-
vealed chromosomal anomalies in 27.5% (25/91) of the in-
formative patients. This frequency must be underestimated
as 104 patients (53.3%) were not studied or had inconclu-
sive results through QF-PCR. Furthermore, structural ano-
malies were not detected using this method. As expected,
an increased frequency of chromosomal anomalies was ob-
served in patients with HPE and associated malformations.
In addition to the usual cytogenetic study, tracing
microdeletions involving genes associated with HPE
through techniques, such as MLPA, contributed signifi-
cantly to the diagnosis. The rate of chromosomal micro-
anomaly detection through MLPA in the present study,
ranging from 10.3% (3/29) to 17.6% (3/17 with normal
karyotype), is not significantly different from the 5% fre-
quency of microdeletions involving the main four HPE
genes in newborns (Bendavid et al., 2006a) or the 9.8% fre-
quency observed in patients without point mutations (Ben-
david et al., 2006b). The frequency of micro-
rearrangements and mutations in the four main HPE genes
varied between cohorts of fetuses and live-born children.
While mutations are more frequent in livebirths, submicro-
scopic deletions occur more frequently in fetuses (Ben-
david et al., 2006a, 2006b, 2009). In the present study,
which primarily included livebirths, the frequency of
microdeletions, 10.3% (2.7-28.5), and mutations, 12/119
(10.1%; 5.6-17.3), are similar in both groups.
Array-CGH studies have reported frequencies of 17%
to 22% losses or gains in the genome of HPE patients, con-
sidering known and new HPE loci (Bendavid et al., 2009;
Mercier et al., 2011). However, the meaning of these
candidate loci in the etiology of HPE was uncertain. In a ge-
notype-first approach study, Rosenfeld et al. (2010) identi-
fied 136 individuals with deletions in any of the 35 selected
HPE loci identified in a cohort of 26,922 patients studied
through array CGH. The authors observed HPE in 13 indi-
viduals, 11 patients with deletions involving the four pri-
mary HPE genes, one patient with a deletion in the HPE8
locus (14q13), and one patient with a deletion in FGF8. The
other six loci involving HPE genes or candidates were only
associated with HPE microforms, but most of the deletions
identified in HPE candidate genes showed no HPE, nor mi-
croforms of HPE.
The phenotype of patients with microdeletions in one
of the four main HPE genes is highly heterogeneous. Simi-
lar to intragenic mutations, these patients present pheno-
types ranging from alobar HPE to microforms (Bendavid et
al., 2007; Rosenfeld et al., 2010). No microdeletions were
observed in the seven patients with HPE-microform or the
patient with 46,XX, inv(5) (p14.3; q23.1), whose brother
and father were carriers with the same inversion, showing
normal results using the P-187 HPE Kit for MLPA, where
probes against the candidate HPE gene, FBXW11, were lo-
cated in 5q35.1. The patient presented with SMMCI, age-
nesis of corpus callosum, iris colobome, ocular hypo-
telorism, and a mild mental deficiency. Additional studies
in this family will be important to determine whether the
gene in this locus is associated with HPE.
The mutation frequency observed in the present study
was 12/119 (10.1%; 5.6-17.3). Dubourg et al. (2004) re-
ported a similar rate of 17% in fetuses and living children
with normal karyotypes, while Nanni et al. (2000) observed
mutation in only one case studied, representing 4.3% of the
sample of newborn cases in a population from California.
Lazaro et al. (2004) observed a similar frequency of 16%
when considering syndromic and nonsyndromic HPE and
patients with midline facial and/or cerebral anomalies with-
out neuroradiological HPE. Although we did not conduct a
functional analysis of the identified mutations, these anom-
alies affected conserved protein regions and therefore can
be considered as contributors to the HPE phenotype.
The mutation ratio is higher in liveborn children
(20% to 23%) than in fetuses (12.5% to 14%), who usually
present more severe phenotypes due to chromosomal ano-
malies (Dubourg et al., 2004; Bendavid et al., 2009). How-
ever, even if most of the sample comprised newborns, the
mutational frequency is low compared with the cited litera-
ture, likely reflecting the high frequency of cases without
karyotype observed in the present study (53.3%).
The frequency of mutations in SHH, 8/119 (6.7%;
3.2-13.2), is consistent with the results obtained in previous
studies. Nanni et al. (1999) observed the same frequency
(6.7%) in 344 HPE patients. Bertolacini et al. (2009) de-
scribed a frequency of 8.1%, and Lazaro et al. (2004) de-
tected mutations in the SHH gene in 8.6% of cases.
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Paulussen et al. (2010) observed a lower frequency of 3.5%
in a Dutch cohort of non-syndromic HPE, including fe-
tuses, neonatal deceased children, children and adults.
Roessler et al. (2012) included the data from Dubourg et al.
(2004) and Paulussen et al. (2010) in their analyses and ob-
served an aggregated frequency of 5.9% in 475 studied in-
dividuals. With the exception of the cohort from Paulussen
et al. (2010), SHH is the most commonly mutated gene
among HPE individuals.
Consistent with the study from Solomon et al. (2012),
we observed the prevalence of missense mutations (6/8,
75%) and a similar prevalence of nonsense (1) and
frameshift (1) mutations in the SHH gene. A nonsense mu-
tation in codon 72 was detected in the patient 818 (Table 2).
A quarter of the mutations described in SHH were nonsense
or frameshift mutations (Roessler et al., 2009b; Solomon et
al., 2012). Except for the mutation p.M457Rfx*18, these
anomalies eliminated the autocatalytic processing site from
the protein and are considered as null alleles (Roessler et
al., 2009b). The mutation observed in the patient 5327 (Ta-
ble 2) was a deletion of the nucleotide at position c.381 in
SHH, resulting in a change in the reading frame and gener-
ating a stop codon at 58 residues after the alteration. This
frameshift mutation resulted in a truncated protein termi-
nating 14 residues before the autocatalytic cleavage site,
likely generating a non-functional allele. The variant c.
482T > A, p.(L161Q), detected in the proband 576 (Table
2), was inherited from her father. This mutation is consid-
ered damaging (score 1.00). It is located in domain N-SHH,
a conserved region that occurs among species, causes the
substitution of a hydrophobic amino acid (leucine) to a hy-
drophilic amino acid (glutamine) and was not observed in
the Exome Variant Server. Solomon et al. (2012) described
the same mutation in a patient with unknown HPE and no
other information about the phenotype. Mutation c. 548G >
A, p.(C183Y) was identified in patient number 2086 (Ta-
ble 2) and was also identified in a female HPE patient de-
scribed by Roessler et al. (2009b), with no detailed clinical
information, who inherited the mutation from her father
(Solomon et al., 2012). This mutation occurred in the same
position of the mutation observed in patient number 81 (Ta-
ble 2) previously described by Orioli et al. (2001). Indeed,
codon 183 is a hot spot for mutations, as this codon was al-
tered in at least four unrelated families: mutation
p.(C183R), detected in a family described by Roessler et al.
(2009b) and Solomon et al. (2012); mutation p.(C183F),
detected in a patient previously described by Orioli et al.
(2001); and the two unrelated probands with mutation
p.(C183Y) described in the present study, Roessler et al.
(2009b), and Solomon et al. (2012). The altered region was
localized in domain N-SHH and is highly conserved among
species. The PolyPhen2 analysis revealed the mutation
p.(C183R) as likely damaging (score of 1.00). The variant
c. 548G > A was not described in the Exome Variant Server
among more than 6,000 sequenced individuals. The alter-
ation c. 718A > C, p.(T240P), detected in patient 2815 (Ta-
ble 2), affects the C-terminal domain of the SHH protein.
Roessler et al. (2009b) reported two mutations affecting the
adjacent amino acid. This region is conserved among dif-
ferent phyla, and this change leads to the substitution of a
threonine, an amino acid with hydrophilic characteristics,
with a hydrophobic proline. This mutation was not de-
scribed in the Exome Variant Server, and the PolyPhen2
analysis considered this mutation as likely damaging (score
of 0.773).
In families where the SHH gene mutation is segregat-
ing, widely variable expressivity among affected members
is observed (Solomon et al., 2012). Indeed, in the present
study, at least half of the probands with mutations in the
SHH gene inherited the mutation from one parent who was
mildly affected. There was no disproportion of sex in the
probands with the SHH mutation (proportion was 1:1), con-
sistent with the results of previous studies (Mercier et al.,
2011; Solomon et al., 2012). The small sample size pre-
vented comparisons of the distribution of HPE types or fa-
cial features.
The SIX3 gene presented a mutation frequency of
2/119 (1.7%; 0.3-6.5), which is not different from the 4%
frequency described by Dubourg et al. (2004) in 200 indi-
viduals with normal karyotypes, including fetuses and liv-
ing children and is also not different from the 5.1%
frequency reported by Mercier et al. (2011). Paulussen et
al. (2010) observed a higher frequency of 10.5%. Muta-
tions in the SIX3 gene have been predominantly observed in
exon 1 (Lacbawan et al., 2009).
The ZIC2 gene has been previously described as the
second most frequently mutated gene in HPE cases
(Dubourg et al., 2007). In the present study, the frequency
was only 2/119 (1.7%; 0.3-6.5), a similar frequency of mu-
tations as observed in the SIX3 gene. Paulussen et al. (2010)
also observed a 10.5% mutation frequency in ZIC2 and in
SIX3 genes, although these frequencies were higher than
the frequencies observed in the present study. Other studies
have reported mutation frequency between 3% and 8.4%
(Brown et al., 2001; Dubourg et al., 2004; Solomon et al.,
2010b; Mercier et al., 2011; Roessler et al., 2012). Patients
presenting mutations in the ZIC2 gene typically have mild
facial defects or no facial anomalies (Brown et al., 2001). It
is likely that there was a bias in the present study towards
more typical faces, which would lower mutation frequency
in gene ZIC2 and increase chromosomal defect rate. The
two mutations in ZIC2 detected in the present study were
observed in patients with semilobar HPE and microce-
phaly, one patient with a relatively non-dysmorphic face,
and another patient presenting a nose cleft (Table 2) (Orioli
et al., 2001; Savastano et al., 2014). Interestingly, four pa-
tients presented with atypical facial clefts. However, the
other patient with a nose cleft showed normal results in the
mutational analysis. Recently, there have been attempts to
establish genotype-phenotype relations in HPE patients
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through studies including hundreds of mutated individuals
for SHH (Solomon et al., 2012), ZIC2 (Solomon et al.,
2010b) and SIX3 genes (Lacbawan et al., 2009). Although
the number of cases in the present study identified with a
chromosomal or gene defect is small (40/195; 20.5%), cer-
tain features that were previously identified in the geno-
type-first approach study of Rosenfeld et al. (2010) as the
possible common cause between Dandy-Walker anomaly
and HPE were observed in the present study. A total of 47
patients presented other cerebral defects besides or instead
of HPE, and eight patients showed Dandy-Walker anoma-
lies: two patients with trisomy 13, one patient with trisomy
18, one patient with a normal karyotype, and the remaining
four patients did not have informed karyotypes.
The absence of mutations in the TGIF gene in our
sample likely reflects sample size constraints, as the fre-
quencies of mutations in this gene have been reported as ap-
proximately 1% (Dubourg et al., 2004).
The frequency of chromosome anomalies and muta-
tions observed in the present study suggests that patients di-
agnosed with HPE must first be karyotyped, as previously
recommended by other authors (Mercier et al., 2010; Pine-
da-Alvarez et al., 2010). Molecular methods, such as
QF-PCR, are efficient for the diagnosis of associated HPE
cases when premature death of newborn precludes cyto-
genetics studies. Isolated HPE cases might present struc-
tural alterations not detected using QF-PCR. In these cases,
the MLPA technique is an alternative for the detection of
gains or losses in key genes associated with HPE. Current
recommendations for the diagnosis of HPE patients also in-
clude array-CGH analyses, as a sensitive and efficient tech-
nique for the identification of gains and losses in known or
new HPE loci, which could clarify the etiology of many ad-
ditional cases (Mercier et al., 2010). A mutation in one of
the four main HPE genes explains only 10% to 20% of
cases, and therefore mutation screening is recommended
after the exclusion of chromosomal anomalies.
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